Elanco Animal Health PE Ratio 2016-2026 | ELAN
Current and historical p/e ratio for Elanco Animal Health (ELAN) from 2016 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Elanco Animal Health PE ratio as of May 15, 2026 is 24.35.
| Elanco Animal Health PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-05-18 | 19.93 | 0.00 | |
| 2026-03-31 | 23.93 | $-0.49 | 0.00 |
| 2025-12-31 | 22.63 | $-0.47 | 0.00 |
| 2025-09-30 | 20.14 | $0.07 | 287.71 |
| 2025-06-30 | 14.28 | $0.87 | 16.41 |
| 2025-03-31 | 10.50 | $0.75 | 14.00 |
| 2024-12-31 | 12.11 | $0.68 | 17.81 |
| 2024-09-30 | 14.69 | $0.40 | 36.73 |
| 2024-06-30 | 14.43 | $-2.55 | 0.00 |
| 2024-03-31 | 16.28 | $-2.65 | 0.00 |
| 2023-12-31 | 14.90 | $-2.50 | 0.00 |
| 2023-09-30 | 11.24 | $-2.32 | 0.00 |
| 2023-06-30 | 10.06 | $-0.23 | 0.00 |
| 2023-03-31 | 9.40 | $-0.05 | 0.00 |
| 2022-12-31 | 12.22 | $-0.16 | 0.00 |
| 2022-09-30 | 12.41 | $-0.28 | 0.00 |
| 2022-06-30 | 19.63 | $-0.36 | 0.00 |
| 2022-03-31 | 26.09 | $-0.77 | 0.00 |
| 2021-12-31 | 28.38 | $-0.99 | 0.00 |
| 2021-09-30 | 31.89 | $-1.52 | 0.00 |
| 2021-06-30 | 34.69 | $-1.60 | 0.00 |
| 2021-03-31 | 29.45 | $-1.30 | 0.00 |
| 2020-12-31 | 30.67 | $-1.30 | 0.00 |
| 2020-09-30 | 27.93 | $-0.58 | 0.00 |
| 2020-06-30 | 21.45 | $-0.26 | 0.00 |
| 2020-03-31 | 22.39 | $-0.03 | 0.00 |
| 2019-12-31 | 29.45 | $0.18 | 163.61 |
| 2019-09-30 | 26.59 | $0.26 | 102.27 |
| 2019-06-30 | 33.80 | $0.43 | 78.60 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $11.500B | $4.715B |
| Elanco Animal Health Incorporated operates as an animal health care company. It develops, manufactures and markets products for companion and food animals. Elanco Animal Health Incorporated is based in Greenfield, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |